NCT05207098招募中不适用
Pilot Study of Radiation-Associated Neurocognitive Function Among Head and Neck Cancer Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 14
- 主要终点
- Number of newly diagnosed head and neck cancer patients recruited and retained on study
研究概览
简要总结
The researchers are doing this study to collect more information about if, and how, neurocognitive function may be affected in people being treated with radiation therapy for head and neck cancer. Part of this study is to see if patients diagnosed with head and neck cancer who are undergoing radiation therapy are able to complete neurocognitive testing and questionnaires at 3 times over a period of 1 year.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pathologically proven diagnosis of a head and neck cancer, specifically these subtypes: nasopharynx, maxillary sinus, tonsil, base of the tongue, oral cavity, or larynx/hypopharynx, oropharynx, cancer of unknown primary, or salivary gland.
- •Ages ≥ 18 and <89 at time of diagnosis.
- •Recently diagnosed with their initial head and neck cancer and able to be consented prior to OR within first week of starting standard of care radiation therapy.
- •Baseline simulation whole-brain MRI or CT available as part of standard of care.
- •Patients diagnosed with cancer, no distant metastases.
- •Karnofsky Performance Status of >= 70 or comparable ECOG performance at enrollment.
- •As per self-report, if currently taking psychoactive medications (excluding gabapentin and including but not limited to antidepressants, and anxiolytics) on a daily basis, dose must have been stable for at least two months prior to enrollment.
- •English fluent as per self-reported fluency of "well' or "very well", and having a reasonable comprehension of the study conversation in the opinion of the research staff).** ** Language verification: Prior to enrollment, all patients will be asked the following two questions by the CRC to verify English fluency necessary for participation in the study:
- •How well do you speak English?
- •Must respond "Well" or "Very well" when given the choices of:
- •Very well, Well, Not well, Not at all, Don't know, or Refused.
- •What is your preferred language for healthcare? Must respond English.
排除标准
- •Patients with multiple primary head and neck cancers, carcinoma of unknown primary, or recurrence.
- •Patients who previously received radiation therapy to the head and neck region as treatment for any prior cancer for any other non-cancerous condition.
- •Patients who had chemotherapy within two years prior to their recent diagnosis of head and neck cancer, such as patients who received chemotherapy as treatment for any other type of cancer or received neoadjuvant chemotherapy prior to surgery to treat their recent head and neck diagnosis. Patients who receive induction chemotherapy just prior to the start of their radiation therapy or receive concurrent chemotherapy to treat their recent head and neck diagnosis are allowed
- •At the discretion of the clinician, patients who are unable to comfortably speak due to symptoms of their cancer or treatment, such as surgery.
- •Pre-existing diagnosis of neurodegenerative disorder that affects cognitive function (e.g. Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Dementia, Seizure Disorders, etc.).
- •As per medical record or self-report, history of stroke or head injury requiring medical care, confirmed structural lesion on neuroimaging, and persistent cognitive difficulties impacting work or daily life or required cognitive rehabilitation.
- •Pre-existing diagnosis of a Schizophrenia Spectrum Disorder, substance use disorder, Bipolar Disorder or Schizotypal personality disorder. Schizophrenia Spectrum Disorders include Schizophrenia, Schizophreniform disorder, Schizoaffective disorder, Delusional disorder, Brief psychotic disorder, and Attenuated Psychotic Disorder.
- •Pre-existing visual or auditory impairment that would preclude ability to complete the assessments (e.g. history of significant macular degeneration or being unable to correct hearing with hearing aids)
结局指标
主要结局
Number of newly diagnosed head and neck cancer patients recruited and retained on study
时间窗: 1 year
have complete the neurocognitive testing
次要结局
未报告次要终点
研究者
研究点 (14)
Loading locations...
相似试验
终止
不适用
A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain TumorsBrain Tumor, PrimaryNCT02006407University of Michigan Rogel Cancer Center5
已完成
不适用
Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain MetastasesCognitive/Functional EffectsMetastatic CancerRadiation ToxicityNCT00007007Radiation Therapy Oncology Group59
进行中（未招募）
不适用
A Study of Cognitive Changes in Patients Receiving Brain RadiationBrain Tumor AdultNCT04390906University of Rochester75
招募中
不适用
Neuromodulation of Brain and Emotional Responses to Psychological StressAnxietyHealthyNCT06603064University of Pittsburgh55
招募中
不适用
Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:Radiation ToxicityMeningiomaNCT06036706Centre Francois Baclesse108